Literature DB >> 15784460

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells.

Leonie S Taams1, Jocea M R van Amelsfort, Machteld M Tiemessen, Kim M G Jacobs, Esther C de Jong, Arne N Akbar, Johannes W J Bijlsma, Floris P J G Lafeber.   

Abstract

The suppressive effects of CD4+CD25+ regulatory T cells (Tregs) on T cells have been well documented. Here we investigated whether human CD4+CD25+ Tregs can inhibit the proinflammatory properties of monocytes/macrophages. Monocytes and T cells were isolated from peripheral blood of healthy volunteers by magnetic cell separation and cocultured for 40 h. Monocytes were analyzed directly for cytokine production and phenotypic changes or repurified and used in T-cell stimulation and lipopolysaccharide challenge assays. Coculture with CD4+CD25+ Tregs induced minimal cytokine production in monocytes, whereas coculture with CD4+CD25- T cells resulted in large amounts of proinflammatory (tumor necrosis factor-alpha, interferon-gamma, interleukin-6) and regulatory (interleukin-10) cytokines. Importantly, when these CD4+CD25+ Treg-treated monocytes were repurified after coculture and challenged with lipopolysaccharide, they were severely inhibited in their capacity to produce tumor necrosis factor-alpha and interleukin-6 compared with control-treated monocytes. In addition, monocytes that were precultured with CD4+CD25+ Tregs displayed limited upregulation of human leukocyte antigen class II, CD40 and CD80, and downregulation of CD86 compared with control-treated monocytes. This altered phenotype had functional consequences, as shown by the reduction in T cell-stimulatory capacity of Treg-treated monocytes. Together, these data demonstrate that CD4+CD25+ Tregs can exert direct suppressive effects on monocytes/macrophages, thereby affecting subsequent innate and adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784460      PMCID: PMC3904343          DOI: 10.1016/j.humimm.2004.12.006

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  39 in total

1.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

Review 3.  Regulation of tumour immunity by CD25+ T cells.

Authors:  Awen Gallimore; Shimon Sakaguchi
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

4.  Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival.

Authors:  Loredana Frasca; Cristiano Scottà; Giovanna Lombardi; Enza Piccolella
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4.

Authors:  C C Chang; R Ciubotariu; J S Manavalan; J Yuan; A I Colovai; F Piazza; S Lederman; M Colonna; R Cortesini; R Dalla-Favera; N Suciu-Foca
Journal:  Nat Immunol       Date:  2002-01-28       Impact factor: 25.606

6.  Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.

Authors:  Edward Y Woo; Heidi Yeh; Christina S Chu; Katia Schlienger; Richard G Carroll; James L Riley; Larry R Kaiser; Carl H June
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

Review 7.  CD4+ CD25+ suppressor T cells: more questions than answers.

Authors:  Ethan M Shevach
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

8.  Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells.

Authors:  Leonie S Taams; Milica Vukmanovic-Stejic; Jay Smith; Padraic J Dunne; Jean M Fletcher; Fiona J Plunkett; Saskia B Ebeling; Giovanna Lombardi; Malcolm H Rustin; Johannes W J Bijlsma; Floris P J G Lafeber; Mike Salmon; Arne N Akbar
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

Review 9.  Cytokine regulation in RA synovial tissue: role of T cell/macrophage contact-dependent interactions.

Authors:  Fionula Brennan; Andrew Foey
Journal:  Arthritis Res       Date:  2002-05-09

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  93 in total

1.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

2.  Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation.

Authors:  Neil R Aggarwal; Kenji Tsushima; Yoshiki Eto; Ashutosh Tripathi; Pooja Mandke; Jason R Mock; Brian T Garibaldi; Benjamin D Singer; Venkataramana K Sidhaye; Maureen R Horton; Landon S King; Franco R D'Alessio
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

3.  Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells.

Authors:  Isabel Barao; Alan M Hanash; William Hallett; Lisbeth A Welniak; Kai Sun; Doug Redelman; Bruce R Blazar; Robert B Levy; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection.

Authors:  Guangming Gong; Lingyun Shao; Yunqi Wang; Crystal Y Chen; Dan Huang; Shuyu Yao; Ximei Zhan; Helene Sicard; Richard Wang; Zheng W Chen
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

5.  The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.

Authors:  Jing Lin; Ming Li; Zhixiao Wang; Shaolin He; Xuming Ma; Dazhu Li
Journal:  J Lipid Res       Date:  2009-12-10       Impact factor: 5.922

6.  Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.

Authors:  Maria I Christodoulou; Efstathia K Kapsogeorgou; Niki M Moutsopoulos; Haralampos M Moutsopoulos
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 7.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Authors:  Stanimir Vuk-Pavlović; Peggy A Bulur; Yi Lin; Rui Qin; Carol L Szumlanski; Xinghua Zhao; Allan B Dietz
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

9.  Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging.

Authors:  Elaine Agius; Katie E Lacy; Milica Vukmanovic-Stejic; Ann L Jagger; Anna-Pia Papageorgiou; Sue Hall; John R Reed; S John Curnow; Judilyn Fuentes-Duculan; Christopher D Buckley; Mike Salmon; Leonie S Taams; James Krueger; John Greenwood; Nigel Klein; Malcolm H A Rustin; Arne N Akbar
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

Review 10.  Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?

Authors:  Leigh R Guerin; Jelmer R Prins; Sarah A Robertson
Journal:  Hum Reprod Update       Date:  2009-03-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.